pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Aug 4·1 min read
save

Hinge Health to acquire Cylinder Health for $105 million, expanding into digestive care

Aug 4, 2026·read at Endpoints ↗DealPositive

Hinge Health, known for virtual physical therapy, announced it will purchase digestive health startup Cylinder Health.

The transaction is a cash deal valued at $105 million, marking Hinge's latest move to broaden its portfolio beyond musculoskeletal conditions.

By adding Cylinder's digestive care platform, Hinge aims to treat additional chronic conditions and diversify its digital health offerings.

The acquisition reflects a growing trend of virtual therapy companies expanding into new therapeutic areas.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Hinge Health will buy Cylinder Health for $105M to enter digestive care”

read at Endpoints ↗
92 words · retrieved Aug 4
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Gastroenterology4Orthopedics

related stories

  • 1d agoOpinion: Doctors should educate patients about ‘Asian glow’ and drinking risksSTAT
  • May 13Opinion: Hospitals are silencing doctors online, and it’s fueling the health misinformation crisisSTAT
  • May 13Safety and Toxicity Management in Metastatic Castration-Resistant Prostate Canceronclive
  • May 13Combination and Sequencing Strategies in Metastatic Castration-Resistant Prostate Canceronclive
  • May 13Patient Selection for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Canceronclive